These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21965552)

  • 1. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
    Ginsburg BC; Schulze DR; Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys.
    Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2017 Aug; 362(2):278-286. PubMed ID: 28533288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
    Rodriguez JS; McMahon LR
    Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
    Schulze DR; Carroll FI; McMahon LR
    Psychopharmacology (Berl); 2012 Aug; 222(3):425-38. PubMed ID: 22374253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.
    Hruba L; McMahon LR
    Eur J Pharmacol; 2014 Mar; 727():35-42. PubMed ID: 24486701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
    Hruba L; Ginsburg BC; McMahon LR
    J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
    Wiley JL; Lowe JA; Balster RL; Martin BR
    J Pharmacol Exp Ther; 1995 Oct; 275(1):1-6. PubMed ID: 7562536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR
    Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
    McMahon LR
    Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.
    Järbe TU; Gifford RS; Makriyannis A
    Eur J Pharmacol; 2010 Dec; 648(1-3):133-8. PubMed ID: 20854804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
    Vann RE; Warner JA; Bushell K; Huffman JW; Martin BR; Wiley JL
    Eur J Pharmacol; 2009 Aug; 615(1-3):102-7. PubMed ID: 19470387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
    Wiley JL; Lefever TW; Cortes RA; Marusich JA
    Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.
    Gatch MB; Forster MJ
    Behav Pharmacol; 2014 Dec; 25(8):750-7. PubMed ID: 25325289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.
    Stewart JL; McMahon LR
    Br J Pharmacol; 2011 Sep; 164(2b):655-66. PubMed ID: 21449917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
    McMahon LR; France CP
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.